BBIO

BBIO Net Income Growth

10.33%TTM

Period ending:

BBIO TTM Net Income YoY %%
BBIO TTM Net Income YoY %44.04%-114.60%
2019-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

BBIO net income growth history

Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 27 observations from Dec 31, 2019 to Jun 30, 2026.

Bridgebio Pharma Inc Net Income Growth — Trailing twelve months (TTM)
Period endingNet Income Growth
10.3263%
-8.6769%
-36.125%
-81.6338%
-71.0847%
-24.0972%
16.7039%
28.3663%
20.7974%
-26.6672%
-33.671%
-24.8337%
-12.4901%
28.6839%
14.4623%
8.3263%
-2.8465%
-14.5982%
-25.3641%
-33.1033%
-43.0077%
-78.5657%
-72.243%
-78.2008%
-75.6892%
-84.5523%
-99.2505%

Compare net income growth

Other companies in Health Care. Each page shows its own reporting periods and currency.

Compare all covered stocks by net income growth →

All BBIO financial metrics · BBIO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.